# Abingworth: portfolio, investments and team > Abingworth is a vc firm based in United Kingdom. 75 investments on record, 4 in the last 12 months, latest Jul 2026. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/abingworth (Millionrounds; every figure on the page links to its filing or article) United Kingdom · [Investor](https://millionrounds.com/investors) # Abingworth Last cheque observed Jul 2026; 75 cheques on record. Email Deploying now New fund $320M, Dec 2025 VC firm Seed Series A Series B Psychedelics Bioimaging Mrna Follow Abingworth and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fabingworth) Deploying now **100%** of best year **4** **cheques in 12 months**, 75 on record Since the last cheque **108** days **00** hrs **00** min **00** sec Median round **$84M** Cheque size, as they say **$15M – $30M** Rounds led **3 of 75** Sole investor **6 rounds** Exits **14 from the portfolio** Mostly in **United States, 62%** Pitch Abingworth ## Abingworth highlights - 01 4 cheques in the last 12 months - 02 Mostly Series B and Series A: 55% of its rounds - 03 Sole investor in 6 rounds, median $15M - 04 14 exits from the portfolio ## What they do > Abingworth has helped young biopharma companies on both sides of the Atlantic turn the latest scientific discoveries into dozens of new treatments for patients. From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** $15M – $30M as they say - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** Psychedelics Bioimaging Mrna - **Based in:** London, United Kingdom - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **75 appearances** - **2026** 4 rounds - **Jul** **[AdvanCell](https://millionrounds.com/company/advancell)** Series D · AU · QRM Capital **$315M** With 16 others - **Jun** **[cAMPfield Therapeutics, Inc.](https://millionrounds.com/company/campfield-therapeutics-inc)** Series A · US · Frazier Life Sciences **$180M** With 7 others - **May** **[Cytospire Therapeutics](https://millionrounds.com/company/cytospire-therapeutics)** Series A · GB · Ventureburn **$83M** With 9 others - **Mar** **[R1 Therapeutics](https://millionrounds.com/company/r1-therapeutics)** Series A · US · TechStartups **$78M** *Led* - **2025** 2 rounds - **Apr** **[Atsena Therapeutics](https://millionrounds.com/company/atsena-therapeutics)** Series C · US · Hatteras Venture Partners **$150M** With 9 others - **Feb** **[AdvanCell](https://millionrounds.com/company/advancell)** Series C · AU · Startup Daily **$112M** *Led* - **2019** 3 rounds - **Dec** **[Jasper Therapeutics](https://millionrounds.com/company/jasper-therapeutics)** Series A · US · FinSMEs **$35M** *Led* - **Dec** **[IFM Therapeutics](https://millionrounds.com/company/ifm-therapeutics)** US · FinSMEs **$56M** With 3 others - **May** **[Phathom Pharmaceuticals](https://millionrounds.com/company/phathom-pharmaceuticals)** US · FinSMEs **$140M** With 8 others - **2018** 1 round - **Jun** **[Sutro](https://millionrounds.com/company/sutro)** Series E · US · FinSMEs **$85M** With 17 others - **2017** 2 rounds - **Oct** **[VirionHealth](https://millionrounds.com/company/virionhealth)** Series A · GB · FinSMEs **$17M** Sole investor - **Jul** **[eFFECTOR Therapeutics](https://millionrounds.com/company/effector-therapeutics)** Series C · US · FinSMEs **$39M** With 10 others - **2015** 3 rounds - **Jul** **[GenSight Biologics](https://millionrounds.com/company/gensight-biologics)** Series B · FR **$36M** With 8 others - **Jul** **[SutroVax](https://millionrounds.com/company/sutrovax)** Series A · US **$22M** With 3 others - **Apr** **[CRISPR THERAPEUTICS](https://millionrounds.com/company/crispr-therapeutics)** Series B · GB **$64M** With 5 others - **2014** 4 rounds - **Jul** **[Gynesonics](https://millionrounds.com/company/gynesonics)** Debt · US **$28M** With 4 others - **May** **[Proteon Therapeutics](https://millionrounds.com/company/proteon-therapeutics)** Series D · US **$45M** With 9 others - **Apr** **[Wilson Therapeutics](https://millionrounds.com/company/wilson-therapeutics)** Series B · SE **$40M** With 3 others - **Feb** **[Thesan Pharmaceuticals](https://millionrounds.com/company/thesan-pharmaceuticals)** Series B **$49M** With 6 others - **2013** 8 rounds - **Nov** **[Pixium Vision](https://millionrounds.com/company/pixium-vision)** Series A · FR · finsmes.com **$19M** With 4 others - **Oct** **[Personalis](https://millionrounds.com/company/personalis)** Series B · US · finsmes.com **$22M** With 2 others - **Jul** **[Dicerna Pharmaceuticals](https://millionrounds.com/company/dicerna-pharmaceuticals)** Series C · US · finsmes.com **$60M** With 8 others - **May** **[Effector Therapeutics](https://millionrounds.com/company/effector-therapeutics)** Series A · US · fiercebiotech.com **$45M** With 6 others - **Apr** **[GenSight Biologics](https://millionrounds.com/company/gensight-biologics)** Series A · FR · finance.yahoo.com **$42M** With 3 others - **Feb** **[Gynesonics](https://millionrounds.com/company/gynesonics)** Debt · US · sec.gov **$22M** With 4 others - **Jan** **[Avillion](https://millionrounds.com/company/avillion)** GB · finsmes.com **Undisclosed** With 1 other - **Jan** **[Labcyte](https://millionrounds.com/company/labcyte)** Series D · US · finsmes.com **$5.3M** With 6 others - **2012** 4 rounds - **May** **[Sonitus Technologies](https://millionrounds.com/company/sonitus-technologies)** Venture · CA · sec.gov **$34K** With 3 others - **May** **[Sonitus Medical](https://millionrounds.com/company/sonitus-medical)** Series D · US · sonitusmedical.com **$25M** With 5 others - **Mar** **[Sientra](https://millionrounds.com/company/sientra)** Series C · US · fis.dowjones.com **$65M** With 2 others - **Jan** **[Prosensa](https://millionrounds.com/company/prosensa)** Venture · NL · reuters.com **$30M** With 6 others - **2011** 2 rounds - **Sept** **[Valeritas](https://millionrounds.com/company/valeritas)** Series C · US · finsmes.com **$150M** With 8 others - **May** **[MD On-Line](https://millionrounds.com/company/md-on-line)** Venture · US · sec.gov **$12M** Sole investor - **2010** 3 rounds - **Nov** **[Syntaxin](https://millionrounds.com/company/syntaxin)** Series C · GB · fiercebiotech.com **$29M** With 6 others - **Oct** **[IS Pharma](https://millionrounds.com/company/is-pharma)** Venture · GB · fis.dowjones.com **$5.7M** Sole investor - **Oct** **[Pathwork Diagnostics](https://millionrounds.com/company/pathwork-diagnostics)** Series C · US · fis.dowjones.com **$30M** With 5 others - **2009** 9 rounds - **Nov** **[Oxagen](https://millionrounds.com/company/oxagen)** Series C · GB · fiercebiotech.com **$27M** With 8 others - **Oct** **[PrimeraDx (Primera Biosystems)](https://millionrounds.com/company/primeradx-primera-biosystems)** Series C · US · onbiovc.com **$20M** With 5 others - **Oct** **[Zogenix](https://millionrounds.com/company/zogenix)** Series B · US · sec.gov **$36M** With 4 others - **Jul** **[Intellikine](https://millionrounds.com/company/intellikine)** Series B · US · onbiovc.com **$51M** With 5 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **20 named** AL **Abingworth Llp** Manager i Filing they signed CG **Christina Gibbs** Authorized Person of the GP of the GP i Filing they signed DL **David Leathers** Director i Filing they signed DL **David Lobe** Authorized Person of the GP of the GP i Filing they signed EM **Elizabeth Muscarella** Authorized Person of the GP of the GP i Filing they signed GL **Genghis Lloyd-Harris** Executive Officer i Filing they signed IM **Its Manager Abingworth LLP** Manager i Filing they signed JA **James Abell** Executive Officer i Filing they signed JA **Jeremy Anderson** Authorized Person of the GP of the GP i Filing they signed JH **John Heard** Executive Officer i Filing they signed KH **Kenneth Haas** Promoter i Filing they signed KV **Kurt Von Emster** Executive Officer i Filing they signed MA **Manager Abingworth LLP** Manager i Filing they signed MB **Michael Bigham** Promoter i Filing they signed RR **Rob Rosen** Authorized Person of the GP of the GP i Filing they signed RR **Robert Rosen** Authorized Person of the GP of the GP i Filing they signed SC **Shelley Chu** Promoter i Filing they signed SB **Stephen Bunting** Executive Officer i Filing they signed TH **Timothy Haines** Executive Officer i Filing they signed VM **Vincent Miles** Promoter i Filing they signed We also hold **27** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. Who backs their funds ## 1 LP on record in Abingworth's funds - **Funds:** 1 The institutions that put money into its funds, which the firm then invests in companies. Source: an LP list. - [**Axon Partners Group** 1 fund](https://millionrounds.com/fund/axon-partners-group) Fund Vintage Committed Abingworth - - ## What they claim to have backed From their own portfolio page (on their website) **0** of 1 we have independently watched raise Ether Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Exits from the portfolio Companies it backed that were later bought or listed **14 in all** **[Prosensa](https://millionrounds.com/company/prosensa)** Bought by BioMarin Pharmaceutical **$840M** Nov 2014 **[Syntaxin](https://millionrounds.com/company/syntaxin)** Bought by [Ipsen](https://millionrounds.com/fund/ipsen) **$206M** Jul 2013 **[Prosensa](https://millionrounds.com/company/prosensa)** Listed **$78M** Jun 2013 **[Portola Pharmaceuticals](https://millionrounds.com/company/portola-pharmaceuticals)** Listed **$100M** May 2013 **[Avila Therapeutics](https://millionrounds.com/company/avila-therapeutics)** Bought by [Celgene](https://millionrounds.com/fund/celgene) **$350M** Jan 2012 **[Intellikine](https://millionrounds.com/company/intellikine)** Bought by [Takeda Pharmaceutical](https://millionrounds.com/fund/takeda-pharmaceutical) **$310M** Dec 2011 **[Clovis Oncology](https://millionrounds.com/company/clovis-oncology)** Listed **$130M** Nov 2011 **[Synosia Therapeutics](https://millionrounds.com/company/synosia-therapeutics)** Bought by Biotie Therapies **$122M** Jan 2011 **[Zogenix](https://millionrounds.com/company/zogenix)** Listed **Undisclosed** Nov 2010 **[Fovea Pharmaceuticals](https://millionrounds.com/company/fovea-pharmaceuticals)** Bought by [Sanofi Aventis](https://millionrounds.com/fund/sanofi) **Undisclosed** Oct 2009 **[Guava Technologies](https://millionrounds.com/company/guava-technologies)** Bought by Millipore **$23M** Feb 2009 **[Ablynx](https://millionrounds.com/company/ablynx)** Listed **Undisclosed** Nov 2007 **[Adiana](https://millionrounds.com/company/adiana)** Bought by [Cytyc](https://millionrounds.com/fund/cytyc) **$215M** Feb 2007 **[Xenogen Corporation](https://millionrounds.com/company/xenogen-corporation)** Bought by Caliper Life Sciences **Undisclosed** Feb 2006 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$320M** raised in Dec 2025 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$84M** the round, not its cheque Alone, median **$15M** Led 3 of 75 rounds **4%** - **Said size:** $15M – $30M - **Sole investor:** 6 rounds - **Last cheque:** Jul 2026 - **Exits:** 14 from the portfolio Rounds by stage said on their site - Series B said *19* - Series A said *17* - Series C *17* - Venture *8* - Series D *5* - Seed said *-* - Growth said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [MPM Capital](https://millionrounds.com/fund/mpm-bioimpact) 10 - [Advanced Technology Ventures](https://millionrounds.com/fund/advanced-technology-ventures) 9 - [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 7 - [SR One](https://millionrounds.com/fund/sr-one) 7 - [Versant Ventures](https://millionrounds.com/fund/versant-ventures) 7 - [Wellcome Trust](https://millionrounds.com/fund/wellcome-trust) 7 **Pitching Abingworth?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Abingworth. A count of rooms they were both in, not a relationship either has claimed. [**MPM Capital** Private equity **10** rounds together](https://millionrounds.com/fund/mpm-bioimpact)[**Advanced Technology Ventures** VC firm **9** rounds together](https://millionrounds.com/fund/advanced-technology-ventures)[**New Enterprise Associates** VC firm **7** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**SR One** Corporate VC **7** rounds together](https://millionrounds.com/fund/sr-one)[**Versant Ventures** VC firm **7** rounds together](https://millionrounds.com/fund/versant-ventures)[**Wellcome Trust** Government **7** rounds together](https://millionrounds.com/fund/wellcome-trust)[**Frazier Healthcare Partners** Private equity **6** rounds together](https://millionrounds.com/fund/frazier-healthcare-partners)[**Novartis Venture Fund** Corporate VC **6** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**Alta Partners** VC firm **5** rounds together](https://millionrounds.com/fund/alta-partners)[**Domain Associates** VC firm **5** rounds together](https://millionrounds.com/fund/domain-associates)[**InterWest Partners** VC firm **5** rounds together](https://millionrounds.com/fund/interwest-partners)[**Atlas Venture** VC firm **4** rounds together](https://millionrounds.com/fund/atlas-venture) ## Recently backed The latest companies Abingworth put money into. [**AdvanCell** $315M · Jul 2026](https://millionrounds.com/company/advancell)[**Atsena Therapeutics** $150M · Apr 2025](https://millionrounds.com/company/atsena-therapeutics)[**Jasper Therapeutics** $35M · Dec 2019](https://millionrounds.com/company/jasper-therapeutics)[**IFM Therapeutics** $56M · Dec 2019](https://millionrounds.com/company/ifm-therapeutics)[**Phathom Pharmaceuticals** $140M · May 2019](https://millionrounds.com/company/phathom-pharmaceuticals)[**VirionHealth** $17M · Oct 2017](https://millionrounds.com/company/virionhealth) ## Quick answers about Abingworth ### What does Abingworth invest in? Abingworth invests most often at Series B and Series A (55% of the rounds on record), in sectors such as Psychedelics, Bioimaging and Mrna. ### How active is Abingworth? 75 investments on record, 4 of them in the last 12 months, and it led 3. The most recent was in Jul 2026. ### What has Abingworth invested in recently? Its most recent investments on record: AdvanCell (Series D, Jul 2026), cAMPfield Therapeutics, Inc. (Series A, Jun 2026) and Cytospire Therapeutics (Series A, May 2026). ### How big are Abingworth's cheques? The median round it joins is $84M. It says it writes cheques of $15M to $30M. ### Does Abingworth lead rounds? Sometimes: it led 3 of its 75 investments on record (4%). ### Where does Abingworth invest? Most of the companies it backs are in the United States (62%), the United Kingdom (18%) and France (8%). ### Is Abingworth investing now? Yes: it is actively investing, with 4 investments in the last 12 months. ### Who does Abingworth invest alongside? Most often MPM Capital (10 rounds together), Advanced Technology Ventures (9 rounds together) and New Enterprise Associates (7 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=abingworth) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=abingworth)